J&J Consumer Health Q2 Results No Help For Avoiding Lowering Full-Year Guidance Again
Executive Summary
J&J reported lower consumer health sales during its latest quarter; consumer health businesses name and branding to be announced in the next few months.
You may also be interested in...
US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?
Consumer health product firms’ vistas include challenges of supply chain disruptions lingering from pandemic’s impact as well as potential for marketplace restrictions as additional varieties of the novel coronavirus spread. Clouds also include shifts in consumer spending, increases in costs caused by inflation and foreign exchange headwinds as the value of the US dollar strengthens against other currencies.
Familiar Leadership For J&J's Planned Consumer Spinoff
J&J's current consumer health division head, Thibaut Mongon, will be at the helm of its planned spinout of the business while Paul Ruh will move to the company was CFO.
Proposal For J&J To Halt Talc Powder Sales Worldwide Fails In Shareholder Vote
Activist investment group Tulipshare’s proposal that J&J fully cease sales of talc-based powders didn’t receive a majority of votes in favor during firm's annual meeting and won’t be forwarded for board’s consideration. Separate proposal for an audit into whether firm marketed products to minority women asbestos concerns was sent to the board.